OHSU in the news

A popular anti-clotting device may do more harm than good

Undark March 18, 2020
In an article on the effectiveness of inferior vena cava, or IVC filters, to prevent blood clots, Vinay Prasad, M.D., M.P.H., says: “The question is always: Is the person who gets a filter, on average, better off by having it? And the answer is, we don’t know. And that’s not a very comfortable thing to tell somebody who you just put a piece of metal in.”

How CAR-T immunotherapy improves quality of life after cancer treatment

Healthline March 18, 2020
In an article describing how CAR-T immunotherapy can help improve quality of life after cancer treatment, Richard Maziarz, M.D., says: “Many patients with this advanced level of disease become depressed and withdraw, but here patients reported improved functional status, physical capabilities, and ability to interact with people.”

Nike, trio of top execs, donate $15 million to virus aid efforts

The Oregonian March 18, 2020
Nike leaders, including Phil and Penny Knight, donate $7 million to support OHSU’s COVID-19 response. Danny Jacobs, M.D., M.P.H., F.A.C.S., says: “People across the state have come together to face this challenge collaboratively, and this support will have a profound impact on our ability to meet it”.
See more stories